Physician profile
Barry Berman
NPI 1578556098
$33,751.80
in general payments reported to CMS, 2019-2025
100 companies · $6,560 in 2025
The $6,560 reported for 2025 was more than what 77% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,680 · 2020: $6,562 · 2021: $4,013 · 2022: $3,730 · 2023: $4,716 · 2024: $4,491 · 2025: $6,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $1,980 · Education: $520 · Long Term Medical Supply Or Device Loan: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,984.43 |
| Consulting Fee | $1,980.00 |
| Education | $519.96 |
| Long Term Medical Supply Or Device Loan | $282.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $4,295.11 | 2019-2025 | Tagrisso, Enhertu, Lynparza |
| Exelixis INC. | $3,909.64 | 2019-2025 | Cabometyx |
| Ipsen Biopharmaceuticals, INC | $2,331.99 | 2019-2025 | Onivyde, Somatuline Depot |
| Janssen Global Services, LLC | $1,980.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $1,891.03 | 2019-2025 | |
| Janssen Biotech, INC. | $1,593.29 | 2019-2025 | Erleada, Darzalex, Rybrevant |
| Pfizer INC. | $1,417.44 | 2019-2025 | |
| Celgene Corporation | $1,134.97 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Merck Sharp & Dohme LLC | $889.12 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Genzyme Corporation | $864.60 | 2019-2025 | |
| Daiichi Sankyo INC. | $795.66 | 2020-2025 | Enhertu, Datroway |
| E.R. Squibb & Sons, L.L.C. | $780.38 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Seagen INC. | $766.19 | 2019-2023 | Tukysa, Padcev, Adcetris |
| Abbvie INC. | $721.25 | 2020-2025 | Venclexta |
| Glaxosmithkline, LLC. | $712.59 | 2020-2025 | Jemperli, Zejula, Ojjaara |
Show all 96 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $555.60 | 2020-2025 | Vpriv, Ninlaro, Fruzaqla |
| Bayer Healthcare Pharmaceuticals INC. | $540.04 | 2020-2025 | |
| Genentech USA, INC. | $539.59 | 2019-2025 | Phesgo, Tecentriq, Polivy |
| Astellas Pharma US INC | $485.17 | 2019-2025 | Xtandi, Xospata, Vyloy |
| Amgen INC. | $438.73 | 2019-2023 | Lumakras, Nplate, Xgeva |
| Eisai INC. | $391.30 | 2020-2025 | |
| Array Biopharma INC | $374.39 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Sirtex Medical INC | $288.49 | 2019-2023 | Sir-Spheres Microspheres |
| Emd Serono, INC. | $276.76 | 2022-2025 | Bavencio, Tepmetko |
| Rigel Pharmaceuticals, INC. | $237.52 | 2023-2025 | Rezlidhia, Tavalisse, Gavreto |
| Pharmacyclics LLC, An Abbvie Company | $234.04 | 2019-2023 | Imbruvica, Epkinly |
| Incyte Corporation | $228.90 | 2019-2025 | Jakafi, Zynyz, Monjuvi |
| Beigene USA, INC. | $227.63 | 2022-2025 | Brukinsa, Tevimbra |
| Jazz Pharmaceuticals INC. | $212.65 | 2021-2025 | |
| Sobi, INC | $197.05 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $190.00 | 2020-2025 | Ultomiris |
| Foundation Medicine, INC. | $188.61 | 2019-2023 | Foundationone Liquid Cdx |
| Lilly USA, LLC | $182.38 | 2019-2024 | Verzenio, Jaypirca |
| Kite Pharma, INC. | $175.81 | 2021-2025 | Yescarta |
| Tersera Therapeutics LLC | $160.26 | 2019-2025 | Zoladex, Xermelo, Quzyttir |
| Aveo Pharmaceuticals, INC. | $153.45 | 2022-2024 | Fotivda |
| Shield Therapeutics INC | $137.24 | 2023-2025 | Accrufer |
| Dendreon Pharmaceuticals LLC | $133.70 | 2019-2025 | Provenge |
| Intuitive Surgical, INC. | $131.40 | 2023 | Da Vinci Surgical System |
| Progenics Pharmaceuticals, INC. | $127.47 | 2022 | |
| Deciphera Pharmaceuticals INC. | $123.36 | 2021-2025 | Qinlock, Tgct |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.07 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $110.55 | 2019-2025 | Libtayo, Lynozyfic |
| Dova Pharmaceuticals | $108.98 | 2020-2021 | |
| Taiho Oncology, INC. | $108.72 | 2021-2024 | |
| Gilead Sciences, INC. | $107.65 | 2019-2024 | |
| Adaptive Biotechnologies Corporation | $104.36 | 2022-2025 | Clonoseq |
| Mirati Therapeutics, INC. | $92.58 | 2023-2024 | Krazati |
| Puma Biotechnology, INC. | $85.93 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $85.00 | 2019-2021 | |
| Blueprint Medicines Corporation | $82.92 | 2020-2025 | Ayvakit |
| Beone Medicines USA, INC. | $78.13 | 2025 | Brukinsa |
| Kyowa Kirin, INC. | $77.47 | 2020-2025 | Poteligeo |
| Shire North American Group INC | $77.17 | 2019 | |
| Thd America, INC. | $73.42 | 2023 | |
| Morphosys, US INC. | $72.67 | 2021-2022 | |
| Karyopharm Therapeutics INC. | $67.33 | 2021-2024 | Xpovio |
| Pharmaessentia USA Corporation | $66.61 | 2023-2025 | Besremi |
| Geron Corporation | $65.68 | 2025 | Rytelo |
| Pharmacosmos Therapeutics INC. | $61.45 | 2023-2025 | Monoferric |
| Legend Biotech USA INC. | $60.83 | 2024-2025 | Carvykti |
| Sun Pharmaceutical Industries INC. | $58.39 | 2021-2024 | |
| Stemline Therapeutics INC. | $54.92 | 2023-2025 | Orserdu |
| Myriad Genetic Laboratories, INC. | $51.35 | 2021-2025 | Myrisk |
| Tempus Ai, INC | $43.44 | 2024 | Xt Cdx |
| Clovis Oncology, INC. | $43.38 | 2019-2021 | |
| Delcath Systems | $42.51 | 2025 | Hepzato Kit |
| Aurobindo Pharma USA, INC. | $42.42 | 2019-2020 | |
| Cti Biopharma Corp. | $40.85 | 2023 | Vonjo |
| Recordati_rare_diseases_inc. | $40.18 | 2024-2025 | Enjaymo, Sylvant |
| Octapharma USA, INC. | $39.87 | 2020-2022 | |
| Acceleron Pharma, INC. | $37.71 | 2020 | |
| Tg Therapeutics, INC. | $34.62 | 2021 | |
| Genmab U.S., INC. | $34.21 | 2023-2024 | Epkinly |
| Acrotech Biopharma INC. | $31.50 | 2022-2024 | Beleodaq |
| Agios Pharmaceuticals, INC. | $31.06 | 2023-2025 | Pyrukynd |
| Accord Healthcare, INC. | $30.49 | 2025 | |
| Fennec Pharmaceuticals, INC. | $30.00 | 2024 | Pedmark |
| Sumitomo Pharma America, INC. | $29.30 | 2025 | Orgovyx |
| Servier Pharmaceuticals LLC | $26.41 | 2022 | |
| Eusa Pharma (US) LLC | $24.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.23 | 2025 | |
| Adc Therapeutics America, INC. | $24.08 | 2025 | |
| Heron Therapeutics, INC. | $23.33 | 2019 | |
| G1 Therapeutics, INC. | $21.88 | 2022 | |
| Azurity Pharmaceuticals, INC. | $21.05 | 2025 | Danziten |
| Immunocore Limited | $19.94 | 2024 | Kimmtrak |
| Emmaus Medical, INC. | $19.70 | 2019 | |
| Novocure INC. | $18.30 | 2025 | Optune Lua (Novottf-200t) |
| Tolmar Pharmaceuticals, INC. | $17.55 | 2019 | |
| Springworks Therapeutics, INC. | $16.63 | 2024 | Ogsiveo |
| Teva Pharmaceuticals USA, INC. | $15.82 | 2019 | |
| Innate Pharma, INC | $13.54 | 2020 | |
| Verastem, INC. | $12.60 | 2020 | |
| Apellis Pharmaceuticals, INC. | $12.44 | 2022 | |
| Veracyte, INC. | $5.18 | 2020 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Enhertu $738Keytruda $583Venclexta $507Kisqali $437Reblozyl $424Xtandi $403Braftovi $325Tukysa $309Mektovi $302Lorbrena $298Jemperli $287Tagrisso $273Erleada $272Zejula $266Sarclisa $261Tavalisse $238Rezlidhia $238Darzalex $235Talzenna $230Opdivo $219Carvykti $217Sir-Spheres Microspheres $215Rybrevant $211Imbruvica $209Orgovyx $206Nubeqa $197Brukinsa $197Lutathera $194Lynparza $189Lenvima $185Pluvicto $180Ojjaara $176Opdualag $168Inlyta $163Tecvayli $162Padcev $161Tivdak $154Xofigo $152Piqray $151Krazati $146Epkinly $144Accrufer $137Yescarta $133Da Vinci Surgical System $131Vpriv $127Phesgo $127Cabometyx $127Elrexfio $126Welireg $118Adcetris $117Ibrance $113Stivarga $105Vitrakvi $105Ninlaro $105Doptelet $103Ultomiris $101Onivyde $100Akeega $89.25Fotivda $88.19Enjaymo $87.20Jakafi $84.79Zoladex $84.21Pomalyst $81.09Xalkori $80.59Fruzaqla $79.02Datroway $77.28Vonjo $76.84Tecentriq $75.76Bosulif $74.86Zepzelca $74.08Iclusig $73.99Bavencio $71.94Besremi $66.61Qinlock $65.98Rytelo $65.68Polivy $62.79Monoferric $61.45Oxbryta $60.80Provenge $59.58Talvey $56.63Orserdu $54.92Alunbrig $54.19Itovebi $53.60Somatuline Depot $52.83Tevimbra $50.30Gavreto $50.25Xpovio $49.14Blenrep $45.68Verzenio $43.88Xt Cdx $43.44Hepzato Kit $42.51Augtyro $41.40Poteligeo $40.44Clonoseq $40.42Jevtana $39.51Xospata $38.05Vyloy $37.86Vonvendi $36.69Lumakras $32.47Kovaltry $31.62
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.